Barriers to Transcatheter Mitral Valve Replacement

Chapter
First Online:

Abstract

For nonsurgical and surgically high risk patients with valvular heart disease, transcatheter valve repair and replacement has become a rapidly growing option. Initially, aortic valve stenosis was considered for transcatheter treatment because of easy access, simple anatomy, straightforward physiology, and most important with calcific stenosis a secure landing spot for transcatheter valve anchorage. However, with transcatheter valve technology improving rapidly, nonsurgical and high-risk surgical patients with mitral regurgitation now have the option to have a transcatheter mitral valve repair.

Keywords

Aortic Valve Mitral Valve Mitral Regurgitation Mitral Valve Replacement Left Ventricular Outflow Tract 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Feldman T, Young A. Percutaneous approach to valve repair for mitral regurgitation. J Am Coll Cardiol. 2014;63:2057–68.CrossRefPubMedGoogle Scholar
  2. 2.
    Glower D, Ailawadi G, Argenziano M, Mack M, Trento A, Wang A, et al. EVEREST II randomized clinical trial: predictors of mitral valve replacement in de novo surgery or after the MitraClip procedure. J Thorac Cardiovasc Surg. 2012;143(4 Suppl):S60–3.CrossRefPubMedGoogle Scholar
  3. 3.
    Banai S, Verheye S, Cheung A, Schwartz M, Marko A, Lane R, et al. Transpical mitral implantation of the Tiara bioprothesis: pre-clinical results. JACC Cardiovasc Interv. 2014;7(2):154–62.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Cheung A, Webb JG, Wong DR, Ye J, Masson JB, Carere RG, et al. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009;87(3):e18–20.CrossRefPubMedGoogle Scholar
  5. 5.
    Anyanwu AC, Adams DH. Transcatheter mitral valve replacement: the next revolution? J Am Coll Cardiol. 2014;64(17):1820–4.CrossRefPubMedGoogle Scholar
  6. 6.
    Schymik G, Würth A, Bramlage P, Herbinger T, Heimeshoff M, Pilz L, et al. Long-term results of transapical versus transfemoral TAVI in a real world population of 1000 patients with severe symptomatic aortic stenosis. Circ Cardiovasc Interv. 2014;8(1)
  7. 7.
    Dvir D. Update from the global valve-in-valve registry, TCT Meeting, Miami 2012.Google Scholar
  8. 8.
    Herrmann HC, Maisano F. Transcatheter therapy of mitral regurgitation. Circulation. 2014;130(19):1712–22.CrossRefPubMedGoogle Scholar
  9. 9.
    De Backer O, Piazza N, Banai S, Lutter G, Maisano F, Herrmann HC, et al. Percutaneous transcatheter mitral valve replacement: an overview of devices in preclinical and early clinical evaluation. Circ Cardiovasc Interv. 2014;7(3):400–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Cheung A, Webb J, Verheye S, Moss R, Boone R, Leipsic J, et al. Short-term results of transapical transcatheter mitral valve implantation for mitral regurgitation. J Am Coll Cardiol. 2014;64(17):1814–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Bapat V, Buellesfeld L, Peterson MD, Hancock J, Reineke D, Buller C, et al. Transcatheter mitral valve implantation (TMVI) using the Edwards FORTIS device. EuroIntervention. 2014;10(Suppl U):U120–8.CrossRefPubMedGoogle Scholar
  12. 12.
    Lutter G, Lozonschi L, Ebner A, et al. First-in-human off-pump transcatheter mitral valve replacement. J Am Coll Cardiol Interv. 2014;7(9):1077–8.CrossRefGoogle Scholar
  13. 13.
    Lutter G, Pokorny S, Frank D, Cremer J, Lozonschi L. Transapical mitral valve implantation: the Lutter valve. Heart Lung Vessel. 2013;5(4):201–6.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  1. 1.Division of Cardiac SurgerySt. Paul’s HospitalVancouverCanada
  2. 2.Division of Cardiac SurgeryUniversity of British ColumbiaVancouverCanada

Personalised recommendations